Codiak BioSciences, Inc. (NASDAQ: CDAK) dipped 19.2% to close at $12.12 after pricing its IPO at $15 per share … Medigen’s COVID-19 vaccine combined with its CpG 1018 Adjuvant received Taiwan …
( read original story …)
The Taiwan NEWS
Codiak BioSciences, Inc. (NASDAQ: CDAK) dipped 19.2% to close at $12.12 after pricing its IPO at $15 per share … Medigen’s COVID-19 vaccine combined with its CpG 1018 Adjuvant received Taiwan …
( read original story …)